German Journal of Pharmaceuticals and Biomaterials is a peer-reviewed english-language open-access journal published by German Journal of Pharmaceuticals and Biomaterials in Germany, operating under an open-access model since 2022. The journal covers Pharmacy and materia medica.
Authors publish in German Journal of Pharmaceuticals and Biomaterials without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, German Journal of Pharmaceuticals and Biomaterials has published 68 articles. Articles are minted with DOIs through the prefix 10.5530. All submissions undergo plagiarism screening before peer review.
Keywords
pharmaceuticals and biomaterials, biochemistry, pharmacology and toxicology, analytical/chromatography techniques, biopharmaceutics, medicinal chemistry
At a glance
- Country
- Germany
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Double anonymous peer review
- OA since
- 2022
- Review time
- 10 weeks
- DOI prefix
10.5530- Plagiarism check
- Yes
ISSN
- 2750-624X
- electronic
- 2750-6258
Frequently asked questions
Is German Journal of Pharmaceuticals and Biomaterials peer-reviewed?
Does German Journal of Pharmaceuticals and Biomaterials charge an article processing charge (APC)?
What subjects does German Journal of Pharmaceuticals and Biomaterials publish?
What languages does German Journal of Pharmaceuticals and Biomaterials accept?
What is the ISSN of German Journal of Pharmaceuticals and Biomaterials?
2750-624X (print) · 2750-6258 (electronic).